Aktiesnakken — Oktober 2010
-
Arzerra går i krig direkte mod Rituxian. De head to head forsøg afgør alt...på et markedet på 36 mia DKK
-
fantasktiske - og længe ventede nyheder - er der noget omkring timing & duration på det studie?
-
men hvornår de læser ud er jeg lidt pas på, men mon ikke der går 12 måneder
-
JPM var rimelig OBS på cash flow i deres august analyse
-
så måske de så småt er på vej imod en holdningsændring ....
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind